Perrigo Banner

Product Search Results

0 products match your search.
Acetaminophen Suppositories USP, 120 mg

Acetaminophen Suppositories USP, 650 mg

Acetylcysteine Injection 200 mg/mL (6g/30mL)

Acetylcysteine Injection 6 g/30 mL (200 mg/1 mL), NOVAPLUS

ACTIDOSE® with SORBITOL

ACTIDOSE®-AQUA

Adapalene Cream, 0.1%
Generic to: Differin® Cream
Alogliptin and Metformin HCl Tablets, 12.5 mg/500 mg; 12.5 mg/1000 mg
Authorized Generic to: Kazano®
Alogliptin and Pioglitazone Tablets, 12.5 mg/15 mg; 12.5 mg/30 mg; 12.5 mg/45 mg; 25 mg/15 mg; 25 mg/30 mg; 25 mg/45 mg
Authorized Generic to: Oseni®
Alogliptin Tablets, 6.25 mg; 12.5 mg; 25 mg
Authorized Generic to: Nesina®
Amiloride HCI Tablets, USP 5 mg
Generic to: Midamor®
Ammonium Lactate Cream 12%

Ammonium Lactate Cream, 12%
Generic to: Lac-Hydrin®
Ammonium Lactate Lotion 12%

Ammonium Lactate Lotion, 12%
Compare to: Lac-Hydrin®
AquaBASE™ Ointment
Compare to: AQUAPHOR®
Aspirin Suppositories, USP

Azelastine HCl Nasal Solution (Nasal Spray), 0.15%
Generic to: Astepro®
Bacitracin

Bacitracin Ophthalmic Ointment USP

Belladonna and Opium Suppositories C-II

Benzoyl Peroxide 10% Acne Medication Wash

Benzoyl Peroxide 10% Aqueous Base, Acne Treatment Gel

Benzoyl Peroxide 2.5% Aqueous Base, Acne Treatment Gel

Benzoyl Peroxide 5% Acne Medication Wash

Benzoyl Peroxide 5% Aqueous Base, Acne Treatment Gel

Betamethasone Dipropionate Cream, USP (Augmented), 0.05%
Generic to: Diprolene AF®
Betamethasone Dipropionate Lotion USP, 0.05%
Generic to: Diprosone®
Betamethasone Valerate Foam, 0.12%
Generic to: Luxiq®
Bisacodyl Suppositories, USP 10 mg
Compare to the Active Ingredient of: DULCOLAX®
Bromocriptine Mesylate Tablets, USP 2.5 mg
Generic to: Parlodel®
Brompheniramine Maleate, Pseudoephedrine Hydrochloride and Dextromethorphan Hydrobromide Syrup
Generic to: Bromfed® DM
Calcipotriene and Betamethasone Dipropionate Ointment, 0.005%/0.064%
Generic to: Taclonex®
Calcitriol Ointment, 3 mcg/g
Generic to: Vectical® Ointment
Calcium Acetate Tablets, USP
Generic to: Eliphos®
Cetirizine Hydrochloride and Pseudoephedrine Hydrochloride Extended Release Tablets, 5mg/120mg
Compare to the Active Ingredient of: Zyrtec-D®
Cetirizine Hydrochloride Syrup, 1mg/mL
Generic to: Zyrtec® Syrup
Cetirizine Hydrochloride Tablets, 10 mg
Compare to the Active Ingredient of: Zyrtec®
Children's Acetaminophen Oral Suspension 160 mg per 5 mL Cherry Flavor
Compare to the Active Ingredient of: Children's Tylenol® Oral Suspension
Children's Acetaminophen Oral Suspension 160 mg per 5 mL Grape Flavor
Compare to the Active Ingredient of: Children's Tylenol® Oral Suspension
Children's Cetirizine Hydrochloride Oral Solution 1mg/mL
Compare to the Active Ingredient of: Children's Zyrtec®
Children's Ibuprofen Oral Suspension 100 mg per 5 mL (teaspoonful) Berry Flavor
Compare to the Active Ingredient of: Children's Motrin®
Children's Ibuprofen Oral Suspension 100 mg per 5 mL (teaspoonful) Grape Flavor
Compare to the Active Ingredient of: Children's Motrin®
Children's Ibuprofen Oral Suspension 100 mg per 5 mL Bubble Gum Flavor
Compare to the Active Ingredient of: Children's Motrin®
Ciclopirox Gel, 0.77%
Generic to: LOPROX®
Ciclopirox Olamine Cream USP, 0.77%
Generic to: Loprox®
Ciclopirox Olamine Topical Suspension USP, 0.77% (w/w) (Lotion)
Generic to: Loprox® Topical Suspension
Ciclopirox Shampoo, 1%
Generic to: Loprox®
Ciclopirox Topical Solution, 8%
Generic to: Penlac®
Clindamycin and Benzoyl Peroxide Topical Gel, 1%/5%
Generic to: Benzaclin®
Clindamycin Phosphate and Benzoyl Peroxide Gel, 1.2%/5%
Generic to: DUAC® Gel
Clindamycin Phosphate Foam, 1%
Generic to: Evoclin®
Clindamycin Phosphate Topical Solution USP, 1%
Generic to: Cleocin-T®
Clindamycin Phosphate Topical Solution USP, 1% (Pledgets)
Generic to: Cleocin-T®
Clindesse®
(clindamycin phosphate) Vaginal Cream, 2%
Clobetasol Propionate Foam (Emollient Formulation) 0.05%
Generic to: Olux-E®
Clobetasol Propionate Foam, 0.05%
Generic to: Olux®
Clobetasol Propionate Gel, 0.05%
Generic to: Temovate®
Clobetasol Propionate Lotion 0.05%

Clobetasol Propionate Shampoo, 0.05%
Generic to: Clobex® Shampoo
Clobetasol Propionate Topical Solution USP, 0.05% Spray
Generic to: Clobex® Spray
Clotrimazole Cream USP, 1%
Compare to the Active Ingredient of: Lotrimin® AF
Clotrimazole Lozenges
Generic to: Mycelex® Troches
COLOCORT® Hydrocortisone Rectal Suspension USP (Retention)
Generic to: Cortenema®
Compound Benzoin Tincture USP

COMPro® Prochlorperazine Suppositories, USP 25 mg

Cyclosporine Injection, USP 250 mg/5 mL (50 mg/mL)

DermaBASE™

Desonide Cream, 0.05%
Generic to: Tridesilon®
Desonide Ointment, 0.05%
Generic to: Tridesilon®
Desoximetasone Ointment USP, 0.25%
Generic to: Topicort®
Desoximetasone Cream USP, 0.25%
Generic to: Topicort®
Dextromethorphan Polistirex Extended-Release Oral Suspension
Compare to the Active Ingredient of: Delsym®
Dibucaine Ointment 1%
Compare to the Active Ingredient of: Nupercainal®
Dihydroergotamine Mesylate Injection, USP 1 mg/mL
Generic to: D.H.E. 45®
Diphenhydramine HCl And Zinc Acetate Cream
Compare to the Active Ingredients of: Extra Strength Benadryl® Cream
Docusate Sodium
Compare to the Active Ingredient of: Colace®
Econazole Nitrate Cream, 1%
Generic to: Spectazole®
Entocort® EC

Ery 2% Pads
Generic to: Erycette®
Erythromycin Ophthalmic Ointment USP

Erythromycin Topical Gel USP, 2%
Generic to: Erygel®
Erythromycin Topical Solution USP, 2%

Estradiol Valerate Injection, USP 100 mg/5 mL
Generic to: Delestrogen®
Estradiol Valerate Injection, USP 200 mg/5 mL
Generic to: Delestrogen®
Evamist®
(estradiol transdermal spray)
EZ Char®

Famotidine for Oral Suspension
Generic to: PEPCID® ORAL SUSPENSION
FattiBASE™

Fenofibrate Tablets 145 mg
Generic to: TriCor®
Fenofibrate Tablets 48 mg
Generic to: TriCor®
Ferrous Gluconate Tablets, USP 324 mg

Ferrous Sulfate Enteric-Coated Tablets 324 mg

Fexofenadine Hydrochloride Tablets, 180 mg
Compare to the Active Ingredient of: Allegra® Allergy
Fexofenadine Hydrochloride Tablets, 60 mg
Compare to the Active Ingredient of: Allegra® Allergy
Flavoxate HCl Tablets 100 mg
Generic to: URISPAS®
Fluocinonide Cream USP, 0.1%
Generic to: Vanos®
Flurandrenolide Lotion USP, 0.05%
Generic to: Cordran®
Fluticasone Propionate (Glucocorticoid) 50 mcg per spray
Compare to the Active Ingredient of: Flonase® Allergy Relief
Fluticasone Propionate Cream, 0.05%
Generic to: Cutivate®
Fluticasone Propionate Lotion, 0.05%
Generic to: Cutivate®
Fluticasone Propionate Ointment, 0.005%
Generic to: Cutivate®
Gentamicin Sulfate Cream USP, 0.1%
Generic to: Garamycin®
Gentamicin Sulfate Ointment USP, 0.1%
Generic to: Garamycin®
Gentamicin Sulfate Ophthalmic Ointment USP, 0.3%

GLUTOL™

GLUTOSE 15™

Glycerin, USP

Guaifenesin and Pseudoephedrine Hydrochloride Extended-Release Tablets, 600 mg/60 mg
Compare to the Active Ingredients of: Mucinex® D
Gynazole-1®
(Butoconazole Nitrate Vaginal Cream USP, 2%)
Halobetasol Propionate Cream, 0.05%
Generic to: Ultravate®
Halobetasol Propionate Ointment, 0.05%
Generic to: Ultravate®
Hemorrhoidal Ointment
Compare to the Active Ingredients of: Preparation H® Ointment
Hydrocodone Bitartrate Chlorpheniramine Maleate and Pseudoephedrine HCl Oral Solution 5 mg/4 mg/ 60 mg per 5 mL CII
Generic to: ZUTRIPRO®
Hydrocortisone 1% - Iodoquinol 1% Cream
Compare to the Active Ingredients of: Vytone®
Hydrocortisone 1% Ointment
Compare to the Active Ingredient of: Cortizone•10®
Hydrocortisone Acetate 1% Pramoxine HCl 1% Cream
Authorized Generic to: Analpram HC® Cream 1%
Hydrocortisone Acetate 2.5% Pramoxine HCl 1% Cream
Authorized Generic to: Analpram HC® Cream 2.5%
Hydrocortisone Acetate 2.5% Pramoxine HCl 1% Cream
Authorized Generic to: Pramosone® Cream 2.5%
Hydrocortisone Acetate Suppositories 25 mg

Hydrocortisone Acetate Suppositories 30 mg

Hydrocortisone Acetate, USP Micronized Powder

Hydrocortisone Cream 1%
Compare to the Active Ingredient of: Cortaid®
Hydrocortisone Cream USP, 2.5%
Generic to: Hytone®
Hydrocortisone Lotion USP, 2.5%
Generic to: Hytone®
Hydrocortisone Ointment USP, 2.5%
Generic to: Hytone®
Hydrocortisone Valerate Cream USP, 0.2%
Generic to: Westcort®
Hydrocortisone, USP Micronized Powder

HYDROmorphone HCl Extended-Release Tablets 12 mg
Generic to: EXALGO®
HYDROmorphone HCl Extended-Release Tablets 16 mg
Generic to: EXALGO®
HYDROmorphone HCl Extended-Release Tablets 8 mg
Generic to: EXALGO®
HYDROmorphone Hydrochloride 3 mg Suppositories CII

Ibuprofen Oral Suspension USP 100mg/5mL
Generic to: Motrin®
Imiquimod Cream, 5%
Generic to: Aldara® Cream 5%
Infants' Concentrated Drops Ibuprofen Oral Suspension 50 mg per 1.25 mL Berry Flavor
Compare to the Active Ingredient of: Motrin® Infants' Drops
Isopropyl Alcohol 99%

Isopropyl Rubbing Alcohol 70% USP

Ketoconazole Foam, 2%
Generic to: Extina®
Ketoconazole Shampoo, 2%
Generic to: Nizoral®
Kionex® Sodium Polystyrene Sulfonate Suspension, USP
Generic to: SPS® SUSPENSION
Lansoprazole Delayed-Release Capsules, 15mg
Compare to the Active Ingredient of: Prevacid® 24HR
Levocetirizine Dihydrochloride Oral Solution 2.5 mg/5 mL (0.5 mg/mL)
Generic to: Xyzal®
Levocetirizine Dihydrochloride Tablets 5mg
Generic to: Xyzal®
Liothyronine Sodium Tablets, USP
Generic to: CYTOMEL®
Liqua-Gel™

Loratadine Tablets, 10 mg
Compare to the Active Ingredient of: Claritin®
Loratadine-D 12 Hour Pseudoephedrine Sulfate 120 mg/Loratadine 5 mg Extended Release Tablets
Compare to the Active Ingredient of: Claritin-D® 12 Hour
Mesalamine Rectal Suspension USP (Enema), 4 g/60mL KIT
Generic to: Rowasa® Kit
Mesalamine Rectal Suspension USP (Enema), 4 grams/60 mL
Generic to: Rowasa®
Methazolamide Tablets, USP 25 mg
Generic to: Neptazane®
Methazolamide Tablets, USP 50 mg
Generic to: Neptazane®
Midazolam HCl Syrup 2 mg/mL CIV

Mineral Oil USP

Mometasone Furoate Cream USP, 0.1%
Generic to: Elocon®
Mometasone Furoate Ointment USP, 0.1%
Generic to: Elocon®
Mometasone Furoate Topical Solution USP, 0.1%
Generic to: Elocon®
Morphine Sulfate Oral Solution 100 mg per 5 mL (20 mg/mL) C-II

Morphine Sulfate Suppositories C-II

Mupirocin Ointment USP, 2%
Generic to: Bactroban®
Muscle Rub
Compare to the Active Ingredients of: Bengay®
Naproxen Sodium Tablets 220 mg
Compare to the Active Ingredient of: Aleve®
Neo-Polycin® HC neomycin and polymyxin B sulfates, bacitracin zinc, and hydrocortisone acetate Ophthalmic Ointment USP

Neo-Polycin® neomycin and polymyxin B sulfates and bacitracin zinc Ophthalmic Ointment USP
Generic to: (Bausch and Lomb) Neomycin and Polymyxin B Sulfates and Bacitracin Zinc
Neomycin and Polymyxin B Sulfates and Dexamethasone Ophthalmic Ointment USP
Generic to: Maxitrol®
Nicotine Polacrilex Gum 2 mg (nicotine) Mint Flavor
Compare to the Active Ingredient of: Nicorette® Gum
Nicotine Polacrilex Gum 4 mg (nicotine) Mint Flavor
Compare to the Active Ingredient of: Nicorette® Gum
Nicotine Polacrilex Lozenge 2 mg (nicotine) Mini Lozenge
Compare to the Active Ingredient of: Nicorette® Mini Lozenge
Nicotine Polacrilex Lozenge 2 mg (nicotine) Mint Flavor
Compare to the Active Ingredient of: Nicorette® Lozenge
Nicotine Polacrilex Lozenge 4 mg (nicotine) Mini Lozenge
Compare to the Active Ingredient of: Nicorette® Mini Lozenge
Nicotine Polacrilex Lozenge 4 mg (nicotine) Mint Flavor
Compare to the Active Ingredient of: Nicorette® Lozenge
Nitroglycerin Lingual Spray
Generic to: Nitrolingual®
Nystatin Cream USP, 100,000 U/G
Generic to: Mycostatin®
Nystatin Ointment USP, 100,000 U/G
Generic to: Mycostatin®
NYSTOP® Nystatin Topical Powder, USP
Compare to: MYCOSTATIN®
Olopatadine Hydrochloride Nasal Spray, 665 mcg
Generic to: Patanase®
Omeprazole Delayed Release Tablets 20mg

ORA-Blend®

ORA-Blend® SF

ORA-Plus®

ORA-Sweet®

ORA-Sweet® SF

Oxymetazoline HCl 0.05%
Compare to the Active Ingredient of: Afrin®
Permethrin Cream, 5%
Generic to: Elimite®
Podocon-25® (25% Podophyllin in benzoin tincture)

Podofilox Topical Solution 0.5%
Generic to: Condylox®
PolyBASE™

Polycin® bacitracin zinc and polymyxin B sulfate Ophthalmic Ointment USP
Generic to: (Bausch and Lomb) Bacitracin Zinc and Polymyxin B Sulfate
Polyethylene Glycol 3350
Compare to the Active Ingredient of: MiraLAX®
Polyethylene Glycol 3350, NF Powder For Oral Solution

Potassium Chloride Extended-Release Capsules USP (600 mg) 8 mEq K

Potassium Chloride Extended-Release Capsules USP (750 mg) 10 mEq K

Potassium Chloride Extended-release Tablets, USP 10 mEq (750 mg)
Generic to: Klor-Con®
Potassium Chloride Extended-release Tablets, USP 8 mEq (600 mg)
Generic to: Klor-Con®
Promethazine Hydrochloride Suppositories USP, 12.5 mg
Generic to: Phenergan®
Promethazine Hydrochloride Suppositories USP, 25 mg
Generic to: Phenergan®
Propylene Glycol, USP

Pseudoephedrine Hydrochloride 30 mg
Compare to the Active Ingredient of: Sudafed® Congestion
Pseudoephedrine Hydrochloride Extended-Release Tablets 120 mg
Compare to the Active Ingredient of: Sudafed® 12 Hour
Puralube® Ointment

Quetiapine Fumarate Extended-Release Tablets, 50 mg; 150 mg; 200 mg; 300 mg; 400 mg
Generic to: Seroquel XR®
Repaglinide Tablets, USP 0.5 mg
Generic to: Prandin®
Repaglinide Tablets, USP 1 mg
Generic to: Prandin®
Repaglinide Tablets, USP 2 mg
Generic to: Prandin®
Salicylic Acid Cream, 6%
Compare to the Active Ingredient of: Salex®
Salicylic Acid Lotion, 6%
Compare to the Active Ingredient of: Salex®
Salicylic Acid Shampoo, 6% (w/w)
Compare to the Active Ingredient of: Salex®
Saline Nasal Spray
Compare to: Ocean® Ingredients
Selenium Sulfide Topical Suspension USP, 2.5% (Lotion)
Generic to: Selsun® Rx
Sodium Polystyrene Sulfonate Suspension, USP 15 g/60 mL

Sulfacetamide Sodium Ophthalmic Ointment USP, 10%
Generic to: Cetamide®
Sulfacetamide Sodium Topical Suspension USP, 10% (Lotion)
Generic to: Klaron®
Suspendol-S™

Tacrolimus Ointment 0.03%
Generic to: Protopic® Ointment 0.03%
Tacrolimus Ointment 0.1%
Generic to: Protopic® Ointment 0.1%
Terconazole Vaginal Suppositories, 80 mg
Generic to: Terazol® 3
Testosterone Cypionate Injection, USP 200 mg/mL C-III
Generic to: Depo® Testosterone
Testosterone Cypionate Injection, USP 2000 mg/10 mL (200 mg/mL) C-III
Generic to: Depo® Testosterone
Testosterone Gel 12.5 mg of testosterone per pump actuation CIII
Generic to: Androgel® 1%
Testosterone Gel 25 mg of testosterone per packet CIII
Generic to: Androgel® 1%
Testosterone Gel 50 mg of testosterone per packet CIII
Generic to: Androgel® 1%
Tretinoin Cream, USP 0.025%; 0.05%; 0.1%
Generic to: Retin-A®
Tretinoin Cream, USP 0.05%
Generic to: Retin-A®
Tretinoin Cream, USP 0.1%
Generic to: Retin-A®
Tretinoin Gel, USP 0.01%
Generic to: Retin-A®
Tretinoin Gel, USP 0.025%
Generic to: Retin-A®
Triamcinolone Acetonide Topical Aerosol USP, 0.147 mg/g
Generic to: Kenalog® Spray
Triamcinolone Acetonide (Glucocorticoid) 55 mcg per spray
Compare to the Active Ingredient of: Nasacort® Allergy 24 HR
Triamcinolone Acetonide Cream USP, 0.025%
Generic to: Kenalog®
Triamcinolone Acetonide Cream USP, 0.1%
Generic to: Kenalog®
Triamcinolone Acetonide Cream USP, 0.5%
Generic to: Kenalog®
Triamcinolone Acetonide Ointment USP, 0.025%
Generic to: Kenalog®
Triamcinolone Acetonide Ointment USP, 0.1%
Generic to: Aristocort®
Triamcinolone Acetonide Ointment USP, 0.5%
Generic to: Aristocort®
Triple Antibiotic Ointment
Compare to the Active Ingredients of: Neosporin®
Trolamine Salicylate 10%
Compare to the Active Ingredient of: Aspercreme®
Trospium Chloride Extended-Release Capsules 60 mg
Generic to: Sanctura XR®
Trospium Chloride Tablets 20 mg
Generic to: Sanctura®
Vitamin A and D Ointment
Compare to the Active Ingredients of: A+D® Original Ointment
Teature Clindamycin and Benzoyl Peroxide Topical Gel
Alogliptin
Generic DPP4i
Important Safety Information
  • Alogliptin is contraindicated in patients with a history of serious hypersensitivity reaction to alogliptin-containing products such as anaphylaxis, angioedema, or severe cutaneous adverse reactions.
  • Acute pancreatitis: There have been postmarketing reports of acute pancreatitis. If pancreatitis is suspected, promptly discontinue Alogliptin.
  • Hypersensitivity: There have been postmarketing reports of serious hypersensitivity reactions in patients treated with Alogliptin such as anaphylaxis, angioedema or severe cutaneous adverse reactions. In such cases, promptly discontinue Alogliptin, assess for other potential causes, institute appropriate monitoring and treatment, and initiate alternative treatment for diabetes. Use caution in a patient with a history of angioedema with another DPP-4i because it is unknown whether such patients will be predisposed to angioedema.
  • Hepatic effects: Postmarketing reports of hepatic failure, sometimes fatal. Causality cannot be excluded. Baseline liver test panel is recommended. If liver injury is detected, promptly interrupt Alogliptin and assess patient for probable cause, then treat cause if possible, to resolution or stabilization. Do not restart Alogliptin if liver injury is confirmed and no alternative etiology can be found.
  • Hypoglycemia: Insulin and insulin secretagogues are known to cause hypoglycemia. A lower dose of the insulin or insulin secretagogue may be required to minimize the risk when used in combination with Alogliptin.
  • Arthralgia: Severe and disabling arthralgia has been reported in patients taking DPP-4 inhibitors. Consider as a possible cause for severe joint pain and discontinue drug if appropriate.
  • Macrovascular outcomes: There have been no clinical studies establishing conclusive evidence of macrovascular risk reduction with Alogliptin or any other anti-diabetic drug.
  • Most common adverse reactions (4% of patients treated with Alogliptin 25 mg and more frequently than in patients who received placebo) were nasopharyngitis (4.4%), headache (4.2%), and upper respiratory tract infection (4.2%).

Patients taking Alogliptin should contact their health care professionals right away if they develop signs and symptoms of heart failure such as:

  • Unusual shortness of breath during daily activities
  • Trouble breathing when lying down
  • Tiredness, weakness, or fatigue
  • Weight gain with swelling in the ankles, feet, legs, or stomach Patients should not stop taking their medicine without first talking to their health care professionals.

Patients should not stop taking their medicine without first talking to their health care professionals.

Indication

Alogliptin is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Alogliptin is not for treatment of type 1 diabetes or diabetic ketoacidosis.

Please see Full Prescribing Information, including Medication Guide for Alogliptin.

Perrigo
©2016 Perrigo Company, plc

check patient preferred tier status and lower generic co-pay options

Cookie Policy

By using our site you consent to the use of cookies in accordance with the terms of our privacy policy.

Hide this message
Perrigo on Facebook Perrigo on Twitter Perrigo on YouTube Perrigo on LinkedIn Perrigo RSS